Back to search results

Telehealth Mindfulness for Autistic Adolescents and Caregivers

This study is exploring if a telehealth mindfulness program called MINDful TIME can help reduce depression and anxiety in adolescents (ages 13-18) with Autism Spectrum Disorder (ASD). Participants will either attend weekly online group meetings with their parent or caregiver for 8 weeks and use a mindfulness app, or just use the mindfulness app daily for 8 weeks. Researchers will compare changes in depression, anxiety, and mindfulness scores between these two groups. To join, adolescents need to be 13-18 years old and have a confirmed ASD diagnosis. The study aims to enroll 160 participants, but its current status is unclear.

Study design
This is an interventional study planning to enroll 160 participants. Participants will be randomized (assigned by chance) to either the MINDful TIME group or a group using a mindfulness mobile app.
What's involved
Participants will either attend weekly 90-minute online group meetings for 8 weeks and use a mindfulness app daily, or use a mindfulness app daily for 8 weeks.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed up at 8 weeks (post-intervention), 2 months, and 6 months after the intervention begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07501286

Telehealth Mindfulness-based Intervention for Adolescents With Autism Spectrum Disorder and Their Caregivers

Recruiting
NAAges 13–18InterventionalTreatment
Nicole Matthews, Ph.D.
~160 participants
Updated 2026-03-30 on ClinicalTrials.gov
What's tested:MINDful TIMEMindfulness Mobile App

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean Change from Baseline in Children's Depression Inventory (CDI) Scores
Measured over Post-intervention (8 weeks); 2-month follow-up; 6-month follow-up
+2 more outcomes measured

Conditions

Autism Spectrum Disorder

Explore related trials

Autism Spectrum Disorder

NCT07501286

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Southwest Autism Research & Resource Center

    Phoenix, Arizonastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Nicole Matthews, Ph.D. · PRINCIPAL_INVESTIGATOR · Southwest Autism Research & Resource Center
  • Blair Braden, Ph.D. · PRINCIPAL_INVESTIGATOR · Arizona State University

Who to contact

Olivia Melita
[email protected]
(480) 603-3285
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adolescents must be ages 13 to 18 years
Formal clinical or educational ASD diagnosis confirmed by the study team (i.e., review of formal diagnostic report from the diagnosing practitioner or Multidisciplinary Evaluation Team report (MET) shared with the research team by the family) )
Must be willing to be randomized to a treatment or delayed treatment control group
Must be able to attend at least 7 of the 8 group meetings
English speaking: Adolescents and their parent/caregivers must be English-speaking because the screening and behavioral measures are in English, as well as the intervention content

Exclusion

Non-verbal participants will be excluded to ensure test compliance and increase sample homogeneity.
Participants with IQ scores \<70 will be excluded because the intervention was developed for individuals without intellectual disability.
Participants with a physical disability or co-occurring condition that may prevent participation in the weekly group meetings (e.g., selective mutism; aggressive behavior; inability to participate in a 90-minute video conference meeting each week)
Participants who report active suicidal ideation

What this trial measures

  • Mean Change from Baseline in Children's Depression Inventory (CDI) ScoresPost-intervention (8 weeks); 2-month follow-up; 6-month follow-up

    Parent-report measure of adolescent depressive symptoms. Scores range from 30 to 90 with higher scores indicating higher levels of depression symptoms.

  • Mean Change from Baseline in Multidimensional Anxiety Scale for Children (MASC) ScoresPost-intervention (8 weeks); 2-month follow-up; 6-month follow-up

    Parent-report measure of adolescent anxiety symptoms. Scores range from 30 to 90 with higher scores indicating higher levels of anxiety symptoms.

  • Mean Change from Baseline in Child and Adolescent Mindfulness Measure (CAMM) ScoresPost-intervention (8 weeks); 2-month follow-up; 6-month follow-up

    Adolescent-report measure of mindfulness. Scores range from 0 to 40 with higher scores indicating higher levels of mindfulness.